IRCCS Giovanni Paolo II Istituto Oncologico

Bari, Apulia 70124

0 studies enrolling now · 1 studies all time

What they study most

Squamous Non-Small Cell Lung Cancer

Studies at this site

• A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131] — Completed